	自己資本および準備金		日付
Acadia Pharmaceuticals	USD 1.25B	20.68M	2026-03
Agios Pharmaceuticals	USD 1.03B	83.09M	2026-06
Akebia Therapeutics	USD 27.38M	5.24M	2026-03
Almirall	EUR 1.53B	43.26M	2026-06
Alnylam Pharmaceuticals	USD 1.35B	278.74M	2026-06
Amarin	USD 443.62M	5.8M	2026-06
Ardelyx	USD 148.62M	18.33M	2026-03
Astellas Pharma	JPY 1.83T	65.92B	2026-03
AstraZeneca	USD 50.3B	2.96B	2026-06
Charles River Laboratories	USD 2.9B	265.94M	2026-03
Coherus Biosciences	USD 61.01M	26.76M	2025-12
Emergent BioSolutions	USD 649.3M	47.9M	2023-12
Halozyme Therapeutics	USD 219.64M	170.82M	2026-03
Incyte	USD 6.34B	721.58M	2026-06
Ironwood Pharmaceuticals	USD -217.14M	44.69M	2026-03
Karyopharm Therapeutics	USD -292.93M	23.67M	2025-12
Lexicon Pharmaceuticals	USD 202.86M	95.32M	2026-03
MacroGenics	USD 21.2M	34.39M	2026-03
Moderna	USD 7.41B	1.24B	2026-03
Myriad Genetics	USD 337.4M	30.6M	2026-03
Pacira	USD 653.89M	39.22M	2026-03
PTC Therapeutics	USD -165.36M	15.1M	2026-06
Puma Biotechnology	USD 115.27M	10.55M	2025-09
Sarepta Therapeutics	USD 1.51B	364.48M	2026-03
Takeda	JPY 7.56T	215.7B	2026-06
Ultragenyx Pharmaceutical	USD -236M	156M	2026-03
Vanda Pharmaceuticals	USD 327.19M	138.81M	2025-12